Evaluation of Apatinib-Related Hypertension and Identification of Clinical Risk Factors

Table 4

Description of apatinib-related HTN.

Parameter	Apatinib-related HTN (N = 25)
SBP change (mm·Hg)	13.83 ± 17.69
DBP change (mm·Hg)	7.82 ± 11.47
Maximal SBP (mm·Hg)	153.24 ± 16.37
Maximal DBP (mm·Hg)	95.20 ± 13.18
Classification of antihypertensive started or intensified n (%)	22 (88.00)
Calcium-channel blockers	15 (68.18)
Beta-blockers	4 (18.18)
Diuretics	3 (13.64)

Data are presented as a number with percent (%). SBP: systolic blood pressure; DBP: diastolic blood pressure; HTN: hypertension.